Hematology NewsFDA grants Hodgkin lymphoma indication for pembrolizumabMarch 15, 2017Aggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology TimesVeterans don’t have higher risk of leukemia, lymphomaMarch 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA approves pembrolizumab to treat cHLMarch 15, 2017Lymphoma & Plasma Cell DisordersPharmacyHodgkin LymphomaAggressive Lymphomas
Hematology TimesFamily history impacts risk of second cancer after HLMarch 14, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesSelinexor trials placed on partial holdMarch 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyAMLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrug receives orphan designation for DLBCLMarch 13, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesStudy confirms increased adiposity in HSCT survivorsMarch 11, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAggressive Lymphomas
Oncology PracticeConnective tissue diseases reported in patients receiving immune checkpoint inhibitorsMarch 3, 2017Patient & Survivor CareImmunotherapyAggressive LymphomasMelanomaImmuno-oncology
Hematology NewsAdding rituximab to reduced intensity conditioning boosts PFSMarch 2, 2017Aggressive LymphomasCellular TherapyFollicular Lymphoma
Hematology TimesPotential therapeutic strategy for BL, DLBCLMarch 2, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesCCSs’ subsequent cancer risk decreased from ’70s to ’90sMarch 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsAggressive Lymphomas
Hematology NewsPhase III trial: VZV protects auto-HCT patientsFebruary 25, 2017Multiple MyelomaT Cell LymphomasMantle Cell LymphomaIndolent LymphomaAggressive LymphomasPreventive CareLymphoma & Plasma Cell Disorders
Hematology TimesDrug granted orphan status for follicular lymphomaFebruary 24, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesFactors linked to B-NHL in Palestinians, IsraelisFebruary 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesEuropean Commission approves rituximab biosimilarFebruary 23, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
